9GRM | pdb_00009grm

Cdc42 in complex with inhibitory peptide

SOLUTION NMR

---

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	0.4 mM [U-13C; U-15N] Cdc42, 0.45 mM None Peptide, 50 mM None sodium phosphate, 150 mM None sodium chloride	90% H2O/10% D2O	200 mM	6.8	1 atm	298	Bruker AVANCE 600
2	3D 1H-15N NOESY	0.4 mM [U-13C; U-15N] Cdc42, 0.45 mM None Peptide, 50 mM None sodium phosphate, 150 mM None sodium chloride	90% H2O/10% D2O	200 mM	6.8	1 atm	298	Bruker AVANCE 600
3	3D 1H-15N TOCSY	0.4 mM [U-13C; U-15N] Cdc42, 0.45 mM None Peptide, 50 mM None sodium phosphate, 150 mM None sodium chloride	90% H2O/10% D2O	200 mM	6.8	1 atm	298	Bruker AVANCE 600
4	2D 1H-15N HSQC	0.4 mM [U-13C; U-15N] Cdc42, 0.45 mM None Peptide, 50 mM None sodium phosphate, 150 mM None sodium chloride	90% H2O/10% D2O	200 mM	6.8	1 atm	298	Bruker AVANCE 600
5	3D 1H-15N NOESY	0.4 mM [U-13C; U-15N] Cdc42, 0.45 mM None Peptide, 50 mM None sodium phosphate, 150 mM None sodium chloride	90% H2O/10% D2O	200 mM	6.8	1 atm	298	Bruker AVANCE 600
6	3D 1H-15N TOCSY	0.4 mM [U-13C; U-15N] Cdc42, 0.45 mM None Peptide, 50 mM None sodium phosphate, 150 mM None sodium chloride	90% H2O/10% D2O	200 mM	6.8	1 atm	298	Bruker AVANCE 600
7	2D 1H-13C HSQC	0.4 mM [U-13C; U-15N] Cdc42, 0.45 mM None Peptide, 50 mM None sodium phosphate, 150 mM None sodium chloride	90% H2O/10% D2O	200 mM	6.8	1 atm	298	Bruker AVANCE 600
14	3D HNCA	0.4 mM [U-13C; U-15N] Cdc42, 0.45 mM None Peptide, 50 mM None sodium phosphate, 150 mM None sodium chloride	90% H2O/10% D2O	200 mM	6.8	1 atm	298	Bruker AVANCE 600
13	3D HN(CO)CA	0.4 mM [U-13C; U-15N] Cdc42, 0.45 mM None Peptide, 50 mM None sodium phosphate, 150 mM None sodium chloride	90% H2O/10% D2O	200 mM	6.8	1 atm	298	Bruker AVANCE 600
12	3D HNCACB	0.4 mM [U-13C; U-15N] Cdc42, 0.45 mM None Peptide, 50 mM None sodium phosphate, 150 mM None sodium chloride	90% H2O/10% D2O	200 mM	6.8	1 atm	298	Bruker AVANCE 600
11	3D HN(COCA)CB	0.4 mM [U-13C; U-15N] Cdc42, 0.45 mM None Peptide, 50 mM None sodium phosphate, 150 mM None sodium chloride	90% H2O/10% D2O	200 mM	6.8	1 atm	298	Bruker AVANCE 600
10	3D HCCH-TOCSY	0.4 mM [U-13C; U-15N] Cdc42, 0.45 mM None Peptide, 50 mM None sodium phosphate, 150 mM None sodium chloride	90% H2O/10% D2O	200 mM	6.8	1 atm	298	Bruker AVANCE 600
9	3D 1H-13C NOESY	0.4 mM [U-13C; U-15N] Cdc42, 0.45 mM None Peptide, 50 mM None sodium phosphate, 150 mM None sodium chloride	90% H2O/10% D2O	200 mM	6.8	1 atm	298	Bruker AVANCE 800
8	3D X-filtered NOESY	0.4 mM [U-13C; U-15N] Cdc42, 0.45 mM None Peptide, 50 mM None sodium phosphate, 150 mM None sodium chloride	90% H2O/10% D2O	200 mM	6.8	1 atm	298	Bruker AVANCE 800

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE	800
2	Bruker	AVANCE	600

NMR Refinement
Method	Details	Software
simulated annealing		CNS

NMR Ensemble Information
Conformer Selection Criteria	structures with the lowest energy
Conformers Calculated Total Number	100
Conformers Submitted Total Number	24
Representative Model	1 (closest to the average)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	chemical shift assignment	CcpNmr Analysis	2.4	CCPN
2	structure calculation	ARIA		Linge, O'Donoghue and Nilges
3	refinement	CNS		Brunger, Adams, Clore, Gros, Nilges and Read
4	peak picking	CcpNmr Analysis	2.4	CCPN